Skip to main content
Aarti Pharmalabs Limited logo

Aarti Pharmalabs Limited — Investor Relations & Filings

Ticker · AARTIPHARM ISIN · INE0LRU01027 LEI · 335800TTAKRBNDK5P363 BSE.NS Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2025-04-25 Regulatory Filings
Country IN India
Listing BSE.NS AARTIPHARM

About Aarti Pharmalabs Limited

https://www.aartipharmalabs.com/

Aarti Pharmalabs Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives. The company specializes in the development and production of complex chemistry-based products for the global pharmaceutical and generic drug industries. Its core portfolio includes APIs across diverse therapeutic areas such as oncology, cardiovascular, and anti-diabetics. Additionally, the company is a major producer of xanthines, including caffeine and theophylline. Aarti Pharmalabs offers comprehensive Contract Development and Manufacturing Organization (CDMO) services, leveraging its integrated research and development capabilities and large-scale manufacturing facilities. The organization maintains high regulatory standards, ensuring compliance with international quality benchmarks to serve a global clientele.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-04-25 English
Board Meeting — Financial Results/Dividend/Other business matters
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing them about a scheduled Board Meeting to consider and approve audited financial results for the quarter and year ended March 31, 2025, and recommendation of dividend. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including board meetings. The document is short (1784 characters) and serves as an intimation or announcement of an upcoming board meeting and financial results, not the financial results or report itself. Therefore, it is an announcement related to board/management information or a regulatory filing. However, since it specifically informs about a Board Meeting, it fits best under Board/Management Information (MANG).
2025-04-25 English
General Updates
Regulatory Filings Classification · 100% confidence The document is a short notice informing the stock exchanges about a change in the email and website address of the company's Registrar and Share Transfer Agent (RTA). It references Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure obligations. The content is an update or announcement rather than a financial report, management change, or other detailed filing. The document length is only 1410 characters, indicating it is a brief announcement. It does not contain financial data, management changes, voting results, or other report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-04-18 English
Press Release
Environmental & Social Information Classification · 95% confidence The document is a press release announcing that Aarti Pharmalabs Limited has achieved approval of its greenhouse gas emission reduction targets by the Science Based Targets initiative (SBTi). It focuses on the company's environmental sustainability milestones, emission reduction commitments, and related strategic goals. There are no financial statements, quarterly or annual financial results, or detailed management discussion of financial performance. The document is a regulatory announcement under SEBI Listing Regulations, specifically a press release about sustainability achievements. This fits best under Environmental & Social Information (SR) as it details the company's ESG-related performance and commitments. The document length is sufficient and contains substantive content about environmental targets, not merely a brief announcement or a certification. Therefore, the classification is SR with high confidence.
2025-04-16 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter and year ended March 31, 2025. It is addressed to stock exchanges and compliance departments, and it is a compliance certificate from the registrar and share transfer agent. The document is short (3127 characters) and does not contain financial statements or detailed financial data. It is a regulatory compliance certificate rather than a financial report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance documents and certifications that do not fit other specific categories.
2025-04-08 English
Amendment(s)
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the execution of an Addendum to the Subscription and Shareholders' Agreement. It references compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure of material events. The content details the nature of the agreement, parties involved, and implications such as the creation of a joint venture. There are no financial statements, earnings data, or management discussion and analysis. The document is an announcement of a corporate event related to capital structure and shareholder agreements, specifically an update on financing arrangements and joint venture formation. It is not a full financial report or earnings release but an update on a capital/financing activity. The document length is about 4108 characters, which is consistent with an announcement rather than a full report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-04-01 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.